1941-2711
Quarterly
No
J AEROSOL MED PULM D
2008
50
UNITED STATES
http://www.liebertpub.com/overview/journal-of-aerosol-medicine-brand-pulmonary-drug-delivery/24/
>12周，或约稿审稿时间
较易平均录用比例
1.8影响因子
呼吸系统小学科
70/108JIF RANK
1507总被引频次
月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
气雾剂医学和肺药物输送杂志是唯一的同行评审的杂志，提供创新的，权威的报道吸入气雾剂和通过肺系统输送药物的健康影响。该杂志是一个领先的专家论坛，讨论的新主题，如雾化化疗，雾化疫苗，确定毒性的方法，和雾化药物的输送插管病人。气溶胶医学和肺药物输送杂志的报道包括:肺部给药气道反应性与哮喘治疗吸入呼吸道中的颗粒和气体吸入剂的毒性作用气溶胶作为研究基本生理现象的工具
http://www.liebertpub.com/forauthors/journal-of-aerosol-medicine-brand-pulmonary-drug-delivery/24/
Journal of Aerosol Medicine and Pulmonary Drug Delivery is the only peer-reviewed journal delivering innovative, authoritative coverage of the health effects of inhaled aerosols and delivery of drugs through the pulmonary system. The Journal is a forum for leading experts, addressing novel topics such as aerosolized chemotherapy, aerosolized vaccines, methods to determine toxicities, and delivery of aerosolized drugs in the intubated patient.Journal of Aerosol Medicine and Pulmonary Drug Delivery coverage includes: Pulmonary drug delivery Airway reactivity and asthma treatment Inhalation of particles and gases in the respiratory tract Toxic effects of inhaled agents Aerosols as tools for studying basic physiologic phenomena
